Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism

Neuropsychopharmacology

Volumn 24, Issue 6, 2001, Pages 671-679

  Adler, Lawrence E ^a   Olincy, Ann ^a   Cawthra, Ellen ^a   Hoffer, Michelle ^a   Nagamoto, Herbert T ^a   Amass, Leslie ^a   Freedman, Robert ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Auditory evoked potential; Cocaine abuse; Nicotine; Nicotinic receptors; Psychosis

Indexed keywords

COCAINE; NICOTINE GUM; NICOTINIC RECEPTOR; PLACEBO;

ADULT; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DETOXIFICATION; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ELECTROENCEPHALOGRAPHY; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ACETYLCHOLINE; ADULT; AUDITORY PERCEPTION; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; CROSS-OVER STUDIES; EVOKED POTENTIALS, AUDITORY; FEMALE; HALLUCINATIONS; HEARING DISORDERS; HUMANS; MALE; NEURAL INHIBITION; NEUROPSYCHOLOGICAL TESTS; NICOTINE; PSYCHOTIC DISORDERS; RECEPTORS, NICOTINIC;

EID: 0035021345     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00242-6     Document Type: Article

References (58)

1. Adler L.E., Gerhardt G.A., Franks R., Baker N., Nagamoto H., Drebing C., Freedman R. Sensory physiology and catecholamines in schizophrenia and mania. Psychiat Res. 31:1990;297-309.
2. Adler L.E., Hoffer L.J., Griffith J., Waldo M., Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiat. 32:1992;607-616.
3. Adler L.E., Hoffer L., Nagamoto H.T., Waldo M.C., Kisley M.A., Griffith J.M. Yohimbine impairs P50 auditory sensory gating in normal subjects. Neuropsycholpharmacology. 10:1994;249-257.
4. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiat. 150:1993;1856-1861.
5. Adler L.E., Pachtman E., Franks R.D., Pecevich M., Waldo M.C., Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiat. 17:1982;639-654.
6. Adler L.E., Pang K., Gerhardt G., Rose G.M. Modulation of the gating of auditory evoked potentials by norepinephrine. Pharmacological evidence obtained using a selective neuro-toxin Biol Psychiat. 24:1988;179-190.
7. Angrist G., Sathanthan G., Wilk S., Gerson S. Amphetamine psychosis. Behavioral and biochemical aspects J Psychiat Res. 11:1974;13-23.
8. Baker N., Alder L.E., Franks R.D., Waldo M., Berry S., Nagamoto H., Muckle A., Freedman R. Neurophysiological assessment of sensory gating in psychiatric inpatients. Comparison between schizophrenia and other diagnoses Biol Psychiat. 22:1987;603-617.
9. Bartlett E., Hallin A., Chapman B., Angrist B. Selective sensitization to the psychosis-inducing effects of cocaine. A possible marker for addiction relapse vulnerability? Neuropsychopharmacology. 16:1997;77-82.
10. Benowitz N.L., Porchet H., Sheiner L., Jacob P. Nicotine absorption and cardiovascular effects with smokeless tobacco use. Comparison with cigarettes and nicotine gum Clin Pharmacol Ther. 44:1988;23-28.
11. Boutros N., Krystal J., Gerlenter J. Sensory gating and cocaine-induced paranoia. Biol Psychiat. 43:1998;89S.
12. Boutros N., Uretsky N., Berntson G., Bornstein R. Effects of cocaine on sensory inhibition in rats. Preliminary data Biol Psychiat. 36:1994;242-248.
13. Boutros N., Zouridakis G., Overall J. Replication and extension of P50 findings in schizophrenia. Clin Electroencephalograp. 22:1991;40-45.
14. Boutros N., Zouridakis G., Rustin T., Peabody C., Warner D. The P50 component of the auditory evoked potential and subtypes of schizophrenia. Psychiat Res. 47:1993;243-254.
15. Bowers M.B., Malison R.T., Seibyl J.P., Kosten T.R. Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal. Biol Psychiat. 43:1998;278-281.
16. Brady K.T., Lydiard R.B., Malcolm R., Ballenger J.C. Cocaine-induced psychosis. J Clin Psychiat. 52:1991;509-512.
17. Briggs C.A., Anderson D.J., Brioni J.D., Buccafusco J.J., Buckley M.J., Campbell J.E., Decker M.W., Donnelly-Roberts D., Elliott R.I., Gopalakrishnan M., Holladay M.W., Hui Y.H., Jackson W.J., Kim D.J., Marsh K.C., O'Neill A., Prendergast M.A., Ryther K.B., Sullivan J.P., Arneric S.P. Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo. Pharmacol Biochem Behav. 57:1997;231-241.
18. Brown R.A., Monti P.M., Myers MG Rivinius T, Dubreuil ME, Rosenhow DJ Depression among cocaine abusers in treatment. Relation to cocaine abuse and alcohol use and treatment outcome Am J Psychiat. 155:1998;220-225.
19. Clementz B.A., Geyer M.A., Braff D.L. P50 suppression among schizophrenic and normal comparison subjects. A methodological analysis Biol Psychiat. 41:1997;1035-1044.
20. Cubells J.F., Kranzler H.R., McCance-Katz E., Anderson G.M., Malison R.T., Price L.H., Gelernter J. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiat. 5:2000;56-63.
21. Cullum C.M., Harris J.G., Waldo M.C., Smernoff E., Madson A., Nagamoto H.T., Griffith J., Adler L.E., Freedman R. Neurophysiological and neuropsychological evidence of attentional dysfunction in schizophrenia. Schiz Res. 10:1993;131-141.
22. Dalack G.W., Becks L., Hill E., Pomerleau O.F., Meador-Woodruff J.H. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology. 21:1999;195-202.
23. 125I-α-bungarotoxin receptor subtypes. Mol Pharmacol. 47:1995;164-171.
24. Doze V.A., Cohen G.A., Madison D.V. Synaptic localization of adrenergic disinhibition in the rat hippocampus. Neuron. 6:1991;889-900.
25. Fein G., Biggins C., MacKay S. Cocaine abusers have reduced auditory P50 amplitude and suppression compared to both normal controls and alcoholics. Biol Psychiat. 39:1996;955-965.
26. Frazier C.J., Buhler A.V., Weiner J.L., Dunwiddie T.V. Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J Neurosci. 18:1998;8228-8235.
27. Freedman R., Adler L.E., Bickford P., Byerley W., Coon H., Cullum M.C., Griffith J.M., Harris J.G., Leonard S., Miller C., Myles-Worsley M., Nagamoto H.T., Rose G.M., Waldo M. Schizophrenia and nicotinic receptors. Harv Rev Psychiat. 2:1994;179-192.
28. Freedman R., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonards S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 94:1997;587-593.
29. Gawin F.H., Kleber H.D., Byck R., Rounsaville B., Kosten T.R., Jatlow P., Morgan C. Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiat. 46:1989;117-121.
30. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;670-671.
31. Griffith J., Waldo M., Adler L.E., Freedman R. Normalization of auditory sensory gating in schizophrenic patients after a brief period for sleep. Psychiat Res. 49:1993;29-39.
32. Griffith J., Hoffer L.D., Adler L.E., Zerbe G.O., Freedman R. Effects of sound intensity on a midlatency evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Psychophysiol. 32:1995;460-466.
33. Griffith J., O'Neill J.E., Petty F., Garver D., Young D., Freedman R. Nicotine receptor desensitization and sensory gating deficits in schizophrenia. Biol Psychiat. 44:1998;98-106.
34. Hogarty G.E., Schooler N.R., Ulrich R., Mussare F., Ferro P., Herron E. Fluphenazine and social therapy in the aftercare of schizophrenic patients. Arch Gen Psychiat. 36:1979;1283-1294.
35. Judd L.J., McAdams L., Budnick B., Braff D.L. Sensory gating deficits in schizophrenia. New results Am J Psychiat. 149:1992;488-493.
36. Kang D.Y., Poole J., McCallin K., Fein G., Vinogradov S. Sensory gating deficit in schizophrenia. Relation to catecholamine metabolites Schizo Res. 24:1997;234.
37. Lindstrom J. Neuronal nicotinic acetylcholine receptors. Narahaski T. Ion Channels. 1996;377-450 Plenum Press, New York.
38. Luntz-Leybman V., Bickford P.C., Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 587:1992;130-136.
39. Manschreck T.C., Laughery J.A., Weisstein C.C., Allen D., Humbleston B., Neville M., Podlewski H., Mitra N. Characteristics of free base cocaine psychosis. Yale J Biol Med. 61:1988;115-122.
40. McDougle C.J., Black J.E., Malison R.T., Zimmerman R.C., Kosten T.R., Heninger G.R., Price L.H. Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiat. 51:1994;713-719.
41. McGehee D.S., Heath M.J., Gelber S., Devay P., Role L.W. Nicotine enhancement of fast excitatory transmission in CNS by presynaptic receptors. Science. 269:1995;1681-1682.
42. Nagamoto H.T., Adler L.E., Waldo M.C., Freedman R. Sensory gating in schizophrenics and normal controls. Effects of changing stimulation interval Biol Psychiat. 25:1989;549-561.
43. Olincy A., Ross R.G., Young D.A., Roath M., Freedman R. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology. 18:1998;175-185.
44. Reid M.S., Mickalian J.D., Deluuchi K.L., Hall M.S., Berger S.P. An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alc Depend. 49:1998;95-104.
45. Reid M.S., Mickalian J.D., Delucchi K.L., Berger S.P. A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects. Neuropsychopharmacology. 20:1999;297-307.
46. Rosse R.B., Alim T.N., Vocci F.J. Jr., Hess A.L., Johri S.K., Deutsch S.I. Greater increases in cocaine cue-induced craving and pupillary size in cocaine addicts endorsing cocaine-induced paranoia. Biol Psychiat. 35:1994;693.
47. Smith D.A., Boutros N.N., Schwarzkopf S.B. Reliability of P50 auditory event-related potential indices of sensory gating. Psychophysiology. 31:1994;495-502.
48. Sorensen S., Johnson S., Freedman R. Persistent effects of amphetamine on cerebellar purkinje neurons following chronic administration. Brain Res. 247:1982;365-371.
49. Stevens K.E., Fuller L.L., Rose G.M. Dopaminergic and noradrenergic modulation of amphetamine-induced changes in auditory gating. Brain Res. 555:1991;91-98.
50. Stevens K.E., Kem W.R., Freedman R. Selective α7 nicotinic receptor stimulation normalizes cocaine-induced loss of hippocampal sensory inhibition in C3H mice. Biological Psychiat. 46:1999;1443-1450.
51. Stevens K.E., Meltzer J., Rose G.M. Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely-moving rats. Psychopharmacology. 119:1995;163-170.
52. Venables P. Input dysfunction in schizophrenia. Prog Exp Pers Res. 1:1964;1-47.
53. Ward P.B., Hoffer L.D., Liebert B.J., Catts S.V., O'Donnell M., Alder L.E. Replication of a P50 auditory gating deficit in Australian schizophrenic patients. Pyschiat Res. 64:1996;121-135.
54. Williamson S., Gossop M., Powis B., Griffiths P., Fountain J., Strang J. Adverse effects of stimulant drugs in a community sample of drug users. Drug Alc Depend. 44:1997;87-94.
55. Wiseman E.J., McMillan D.E. Rationale for cigarette smoking and for mentholation preference in cocaine- and nicotine-dependent outpatients. Comprehen Psychiat. 39:1998;358-363. a.
56. Wiseman E.J., McMillan D.E. Relationship of cessation of cocaine use to cigarette smoking in cocaine-dependent outpatients. Am J Drug Alc Abuse. 24:1998;617-625. b.
57. Yui K., Goto K., Ikemoto S., Ishiguro T. Monoamine neurotransmitter metabolites and spontaneous recurrence of methamphetamine psychosis. Brain Res Bull. 43:1997;25-33.
58. Yui K., Goto K., Ikemoto S., Ishiguro T., Angrist B., Duncan G.E., Sheitman B.B., Lieberman J.A., Bracha S.H., Ali S.F. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia. The role of sensitization Molec Psychiat. 4:1999;512-523.